AC Immune SA - Common Stock (ACIU)
2.7200
+0.0200 (0.74%)
AC Immune S.A. is a biotechnology company focused on developing therapies and diagnostics for neurodegenerative diseases, particularly Alzheimer's disease and other proteinopathies
The company utilizes its innovative approach to identify and target misfolded proteins that are implicated in these conditions. By leveraging advanced technology platforms, AC Immune is engaged in the discovery and development of disease-modifying treatments and biomarkers, aiming to address significant unmet medical needs in the field of neurology and enhance the understanding of these complex diseases.
Frequently Asked Questions
Is AC Immune SA - Common Stock publicly traded?
Yes, AC Immune SA - Common Stock is publicly traded.
What exchange does AC Immune SA - Common Stock trade on?
AC Immune SA - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for AC Immune SA - Common Stock?
The ticker symbol for AC Immune SA - Common Stock is ACIU on the Nasdaq Stock Market
What is the current price of AC Immune SA - Common Stock?
The current price of AC Immune SA - Common Stock is 2.720
When was AC Immune SA - Common Stock last traded?
The last trade of AC Immune SA - Common Stock was at 12:33 pm EST on February 6th, 2025